Track topics on Twitter Track topics that are important to you
Biogen Inc. is acquiring Pfizer Inc.’s casein kinase 1 (CK1) inhibitor PF05251749 for patients with behavioral and neurolog...
Original Article: Biogen pays up to $710mm for Pfizer's CK1 inhibitor for CNS conditionsNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...